Oncology Archives - Infectious Disease Advisor

Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records

By

September 17, 2021

Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.

HIV/AIDS

Combination Antiretroviral Therapy and CD4/CD8 Ratio on the Risk for Kaposi Sarcoma, Non-Hodgkin Lymphoma in Patients With HIV Infection

By

Sweta Gupta

September 15, 2021

Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.

Individuals on PrEP who become infected with HIV, such as those with poor adherence to treatment, may have delayed seroconversion on blood-based and oral-fluid-based rapid antibody tests.2 In one study, oral antibody reactivity was first observed a median of 125 days (range, 14-547 days) after HIV RNA or antibodies were observed in the blood.13 In another study, individuals who received PrEP were 3.49 times more likely than those on placebo to experience a delay of >100 days in detecting the infection.14 Based on these and other findings in the literature, it has been suggested that laboratory-based serum or plasma HIV tests should be used whenever possible to monitor individuals on PrEP.2 Additionally, in the setting of known or suspected poor PrEP adherence, the threshold for augmenting p24/IgM/IgG assays with NAT should be lowered.2

COVID19, News

COVID-19 Immune Response Appears Strong in Cancer Patients

August 26, 2021

Vast majority show seropositivity four months after the second COVID-19 vaccine dose

General Infectious Disease

Cutaneous Beta-HPV May Up Risk for Cutaneous Squamous Cell Carcinoma

August 13, 2021

Cutaneous beta-human papillomavirus (HPV) may predict development of cutaneous squamous cell carcinoma (cuSCC).

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.

News

Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

By

Alan P. Lyss, MD

August 9, 2021

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.

The test can accurately detect cancer and predict where it is located, according to researchers.

Prevention

Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening

By

Leah Lawrence

August 4, 2021

The test can accurately detect cancer and predict where it is located, according to researchers.

The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

General Infectious Disease

Floxacin Antibiotics May Augment Treatment of Lung and Bladder Cancers by Inhibiting RSK4

By

Andrea S. Blevins Primeau, PhD, MBA

August 2, 2021

RSK4-targeting floxacins could boost the efficacy of chemotherapy.

COVID19

How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging

By

Jonathan Goodman, MPhil

July 26, 2021

Education, communication, and coordination are key.

Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia.

COVID19

Seroconversion After Full COVID-19 Vaccination Lower With Hematologic Malignancies, Lowest With Multiple Myeloma

By

Jennifer Larson

July 23, 2021

A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer.

COVID19

Mortality Risk Factors in Patients With Cancer and COVID-19 Identified

By

Jody A. Charnow

July 22, 2021

Investigators zero in on mortality risk factors in patients with cancer who contract COVID-19.